Similar results were seen in an A20 lymphoma mouse model which showed coexpression of PD-1 and TIGIT, and near complete disappearance of tumor was seen when mice were treated with both anti-PD-1 and anti-TIGIT antibodies [55]. Here, TIGIT is linked to lymphoma.